Neuroscience News

A new study in rats by Institute affiliate Raag Airan — supported by a Wu Tsai Neuro seed grant — looked at whether ketamine’s effects depend on opioid pathways and uncovered a surprising difference between males and females.

This week we talk with Jaimie Henderson, a Stanford neurosurgeon leading groundbreaking research in brain-machine interfaces.

A 3D variation of pooled CRISPR screens could connect the dots between autism spectrum disorder genetics and cell fate pathways in the developing brain.

How to know if your organs are ‘older’ than you are, and ways to slow down biological aging according to Knight Initiative director Tony Wyss-Coray and others.

In a study supported by Wu Tsai Neuro's Neurochoice Initiative, researchers have delved into the complex relationship between brain activity and the risk of relapse in individuals recovering from stimulant addiction.

Knight Initiative director Tony Wyss-Coray and others are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age.

We are proud to welcome the 2024 Neurosciences Postdoctoral Scholars — ten young scientists pursuing novel, multi-disciplinary approaches to understanding the workings of the brain.

Stanford Hospital brings together two autopsy rooms, the morgue, including bereavement and viewing rooms, as well as decedent care team offices. The new space allows for more advanced research for the Knight Initiative for Brain Resilience and others.

Stanford Medicine researchers, including Wu Tsai Neuro affiliate Nolan Williams, find that ibogaine, a plant-based psychoactive compound, safely led to improvements in depression, anxiety and functioning among veterans with traumatic brain injuries.

Stanford Medicine scientists, including Wu Tsai Neuro affiliates David Spiegel and Nolan Williams, used transcranial magnetic stimulation to temporarily enhance hypnotizability in patients with chronic pain, making them better candidates for hypnotherapy.

With limited therapeutic options available, Wu Tsai Neuro affiliate Michelle Monje and team have turned to studying the growth patterns of brain tumors that occur in glial cells to identify new treatment avenues.

The science to advance our understanding of the aging process—and to potentially slow it down—has made important strides. One of the leading scientists responsible for this work is Professor Tony Wyss-Coray, whose work has focused on brain aging.

The Wu Tsai Neurosciences Institute at Stanford University is proud to announce the recipients of its fifth round of Seed Grants.

A new study co-authored by Knight Initiative Director Tony Wyss-Coray demonstrates a simple way of studying organ aging by analyzing distinct proteins in blood, enabling the prediction of individuals’ risk for diseases.

It turns out that your chronological age really is just a number. What’s more important for knowing disease risk is the biological age of each of your organs.

In today’s mostly plague- and famine-free world, if you can avoid more modern scourges like gun and car violence, you can expect your death to arrive not with a bang but a whimper; when one of your organs sput-sput-sputters out.